Alphabet sees progress in breast cancer care with AI

Ruth Porat, chief financial officer of Google parent company Alphabet, said the company is making progress in breast cancer care thanks to AI, according to a report by CNBC.

While speaking at the World Economic Forum, Porat discussed the company’s recent claim that it created AI technology that could accurately distinguish a slide with metastatic cancer and ones without cancer “99 percent of the time.” The findings were first detailed in a blog post last October, according to the report.

She also noted the company needed less data than before to see “impactful results from AI.”

“We needed only hundreds of biopsies from breast cancer patients—hundreds—in order to have a breakthrough in metastatic breast cancer because of the developments in AI,” Porat said in the report.

To read the report, click the link below.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”